What Researchers Did
Researchers conducted a literature review and convened an expert panel to establish multidisciplinary guidelines for the use of hyperbaric oxygen in preventing and managing osteoradionecrosis of the jaw at their institution.
What They Found
After evaluating seven studies, the researchers found no consistent evidence supporting the routine use of hyperbaric oxygen for either the prevention or management of osteoradionecrosis of the jaw. The existing literature on hyperbaric oxygen for this condition was deemed controversial and inconclusive.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis of the jaw should be aware that current evidence does not consistently support the routine use of hyperbaric oxygen for prevention or management. Treatment decisions should therefore focus on other established therapies, as hyperbaric oxygen may not be a standard beneficial intervention.
Canadian Relevance
This study has no direct Canadian connection as it is a multidisciplinary guideline developed by a U.S. institution. However, its findings on the lack of consistent evidence for hyperbaric oxygen in osteoradionecrosis of the jaw could inform clinical practice globally.
Study Limitations
A key limitation is that the available literature on osteoradionecrosis of the jaw is difficult to compare due to a lack of universally accepted classification and staging systems, making definitive conclusions challenging.